Esma Alp Demir, PhD

Esma Alp Demir, PhD has diverse work experience in the field of formulation science and cancer research. Esma currently holds the position of Formulation Scientist at KaloCyte, Inc., which they started in February 2022. Prior to this, they also held the same role at the same company.

Before joining KaloCyte, Inc., Esma worked as a Research Associate at The Center for Cancer Research and Therapeutic Development from November 2019 to February 2022. In this role, they performed and assisted in research projects related to prostate cancer molecular biology. Esma designed experiments to explore the underlying mechanisms in castration-resistant prostate cancer using molecular biology analysis techniques such as Western blotting. Additionally, they identified and characterized polymeric vehicles for delivering conventional prostate cancer agents using emulsification-based techniques.

Esma Alp Demir, PhD, has a strong educational background in chemistry and nanotechnology. Esma obtained their Bachelor's degree in Chemistry from Hacettepe University in 2007. Esma went on to pursue further studies in the field, earning a Master's degree in Nanotechnology and Nanomedicine from Hacettepe University in 2011. Esma then continued their academic journey and obtained a Doctor of Philosophy (PhD) in Nanotechnology & Nanomedicine from Hacettepe University in 2021.

Throughout their academic career, Esma also gained research experience in the United States. From 2016 to 2017, they worked as a Visiting Researcher in Chemistry at the State University of New York at Oswego. Later, from 2014 to 2019, they served as an Exchange Research Scholar at the Cancer Research Center of the University at Albany, SUNY.

Based on the provided information, it can be concluded that Esma Alp Demir is a highly qualified researcher with a specialization in nanotechnology and nanomedicine, particularly in the area of cancer research.